{"id":467,"date":"2026-08-28T06:56:05","date_gmt":"2026-08-28T06:56:05","guid":{"rendered":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/"},"modified":"2026-08-28T07:31:46","modified_gmt":"2026-08-28T07:31:46","slug":"mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/de\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/","title":{"rendered":"MK-677 \/ Ibutamoren: Klinischer Status, Herzinsuffizienzsignal und wesentliche Fragen"},"content":{"rendered":"<p class=\"pim-standfirst wp-block-paragraph\">MK-677, MK-0677 und ibutamoren sind Namen, die in derselben Entwicklungsgeschichte vorkommen. Das Vorhandensein von Studien am Menschen bedeutet nicht, dass es sich bei dem Wirkstoff um ein zugelassenes Medikament handelt, und es werden auch keine Studien gel\u00f6scht, die keinen funktionellen Nutzen zeigten oder Sicherheitsbedenken aufwarfen.<\/p><div class=\"wp-block-group pim-key-takeaways\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><h2 class=\"wp-block-heading\">Was die Aufzeichnung zeigt<\/h2><ul class=\"wp-block-list\"><li>Ibutamoren ist kein von FDA zugelassener Wirkstoff.<\/li><li>Eine H\u00fcftfrakturstudie mit 123-Patienten wurde nach einem Signal einer kongestiven Herzinsuffizienz vorzeitig abgebrochen.<\/li><li>Identit\u00e4t und Test m\u00fcssen die freie Form von Ibutamoren von Ibutamorenmesylat unterscheiden.<\/li><\/ul><\/div><\/div><figure class=\"wp-block-image size-full pim-article-figure\"><img loading=\"lazy\" decoding=\"async\" width=\"1536\" height=\"1024\" src=\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828.png\" alt=\"Wissenschaftler \u00fcberpr\u00fcft Forschungsdaten zu pulsierendem Wachstumshormon und IGF-1\" class=\"wp-image-459\" srcset=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828.png 1536w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828-300x200.png 300w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828-1024x683.png 1024w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/gh-secretagogue-research-20260828-768x512.png 768w\" sizes=\"auto, (max-width: 1536px) 100vw, 1536px\" \/><figcaption class=\"wp-element-caption\">Originale redaktionelle Illustration zur Identifizierung des Forschungsthemas. Es stellt keine Katalogcharge, kein zugelassenes Medikament, kein Testergebnis oder keine klinische Verwendung dar.<\/figcaption><\/figure><h2 class=\"wp-block-heading\">Die Identit\u00e4ts- und Beweisgrenze<\/h2><p class=\"wp-block-paragraph\">Ein Zertifikat sollte die genaue molekulare Form angeben und nicht den Namen des Elternteils und Mesylat austauschbar verwenden. Molekularmasse, Probenberechnung und Inhalt pro Beh\u00e4lter h\u00e4ngen von dieser Wahl ab.<\/p><div class=\"wp-block-group pim-evidence-table\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><div class=\"pim-evidence-row\"><strong>Synonyme in der Literatur<\/strong><span>MK-677, MK-0677, Ibutamoren<\/span><\/div><div class=\"pim-evidence-row\"><strong>Salz-\/Formproblem<\/strong><span>Ibutamoren vs. Ibutamorenmesylat<\/span><\/div><div class=\"pim-evidence-row\"><strong>Sicherheitskontext<\/strong><span>Glukose-\/Insulineffekte, \u00d6deme und CHF-Signal<\/span><\/div><\/div><\/div><h2 class=\"wp-block-heading\">Was in die Materialakte geh\u00f6rt<\/h2><p class=\"wp-block-paragraph\">In Marketingzusammenfassungen wird h\u00e4ufig die Steigerung der IGF-1 oder der fettfreien Masse hervorgehoben und die negativen funktionellen Ergebnisse weggelassen. Eine vertretbare Seite h\u00e4lt die Ergebnishierarchie intakt und zitiert die gestoppte H\u00fcftfrakturstudie sowie die l\u00e4ngere Studie mit gesunden, \u00e4lteren und erwachsenen Patienten.<\/p><h2 class=\"wp-block-heading\">Redaktionelle Regel<\/h2><p class=\"wp-block-paragraph\">Verwenden Sie den genauen Interventionsnamen, das Modell, die Population und den Endpunkt aus dem zitierten Datensatz. Wandeln Sie eine Assoziation, einen Mechanismus, ein Tierergebnis, eine genehmigte Fertigarzneimittelaufzeichnung oder einen analytischen Test nicht in einen Anspruch \u00fcber eine nicht verwandte Katalogcharge um.<\/p>","protected":false},"excerpt":{"rendered":"<p>MK-677, MK-0677 und ibutamoren sind Namen, die in derselben Entwicklungsgeschichte vorkommen. Das Vorhandensein von Studien am Menschen bedeutet nicht, dass es sich bei dem Wirkstoff um ein zugelassenes Medikament handelt, und es werden auch keine Studien gel\u00f6scht, die keinen funktionellen Nutzen zeigten oder Sicherheitsbedenken aufwarfen.<\/p>","protected":false},"author":1,"featured_media":632,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"351","pim_article_type":"Evidence and material-quality guide","pim_evidence_level":"Randomized trials and FDA compounding review","pim_reviewer":"NHD evidence editorial workflow","pim_reviewed_date":"2026-08-28","pim_editorial_note":"Source-checked on 2026-08-28. Null findings and study limitations are retained. This is not independent peer review, medical advice, a customer case, or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"At least two linked primary or authoritative records and an explicit evidence boundary are present.","pim_creation_method":"The editorial workflow starts with linked peer-reviewed papers, trial registries or regulatory records; extracts the population or model, endpoints, numerical results and limitations; and separates the studied intervention from catalog material. AI-assisted drafting was used to structure the first version. Claims, figures, evidence labels and limitations were checked against the linked records in the site editorial workflow. This is not independent peer review.","pim_sources":"[{\"title\":\"MK-677 in healthy older adults: two-year randomized trial\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18981485\/\",\"note\":\"Body composition, function and glucose findings; PMID 18981485.\"},{\"title\":\"MK-0677 phase IIb hip-fracture study\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21067829\/\",\"note\":\"Early termination after CHF signal; PMID 21067829.\"},{\"title\":\"FDA Pharmacy Compounding Advisory Committee meeting materials\",\"url\":\"https:\/\/www.fda.gov\/advisory-committees\/advisory-committee-calendar\/october-29-2024-meeting-pharmacy-compounding-advisory-committee-10292024\",\"note\":\"FDA assessment materials for ibutamoren and ipamorelin.\"}]","footnotes":""},"categories":[20],"tags":[],"class_list":["post-467","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-evidence-quality-guides"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>MK-677 Clinical Status, Safety Signals &amp; Quality Questions<\/title>\n<meta name=\"description\" content=\"MK-677, MK-0677 and ibutamoren are names found across the same development history. The existence of human trials does not mean the compound is an approved\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/de\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MK-677 \/ Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions\" \/>\n<meta property=\"og:description\" content=\"MK-677, MK-0677 and ibutamoren are names found across the same development history. The existence of human trials does not mean the compound is an approved\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/de\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-28T06:56:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-28T07:31:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"MK-677 \\\/ Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions\",\"datePublished\":\"2026-08-28T06:56:05+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/\"},\"wordCount\":242,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp\",\"articleSection\":[\"Evidence &amp; Quality Guides\"],\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/\",\"name\":\"MK-677 Clinical Status, Safety Signals & Quality Questions\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp\",\"datePublished\":\"2026-08-28T06:56:05+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"description\":\"MK-677, MK-0677 and ibutamoren are names found across the same development history. The existence of human trials does not mean the compound is an approved\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp\",\"width\":1536,\"height\":960,\"caption\":\"Article-specific editorial image.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MK-677 \\\/ Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/de\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"MK-677 Klinischer Status, Sicherheitssignale und Qualit\u00e4tsfragen","description":"MK-677, MK-0677 und ibutamoren sind Namen, die in derselben Entwicklungsgeschichte vorkommen. Das Vorhandensein von Versuchen am Menschen bedeutet nicht, dass die Verbindung zugelassen ist \u2026","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/de\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/","og_locale":"de_DE","og_type":"article","og_title":"MK-677 \/ Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions","og_description":"MK-677, MK-0677 and ibutamoren are names found across the same development history. The existence of human trials does not mean the compound is an approved\u2026","og_url":"https:\/\/nhdbio.com\/de\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/","og_site_name":"NHD","article_published_time":"2026-08-28T06:56:05+00:00","article_modified_time":"2026-08-28T07:31:46+00:00","og_image":[{"width":1536,"height":960,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Verfasst von":"NHD Technical Team","Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"MK-677 \/ Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions","datePublished":"2026-08-28T06:56:05+00:00","dateModified":"2026-08-28T07:31:46+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/"},"wordCount":242,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp","articleSection":["Evidence &amp; Quality Guides"],"inLanguage":"de","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/","url":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/","name":"MK-677 Klinischer Status, Sicherheitssignale und Qualit\u00e4tsfragen","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp","datePublished":"2026-08-28T06:56:05+00:00","dateModified":"2026-08-28T07:31:46+00:00","description":"MK-677, MK-0677 und ibutamoren sind Namen, die in derselben Entwicklungsgeschichte vorkommen. Das Vorhandensein von Versuchen am Menschen bedeutet nicht, dass die Verbindung zugelassen ist \u2026","breadcrumb":{"@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions-featured-v2.webp","width":1536,"height":960,"caption":"Article-specific editorial image."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/mk-677-ibutamoren-clinical-status-safety-signals-and-quality-questions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"MK-677 \/ Ibutamoren: Clinical Status, Heart-Failure Signal and Material Questions"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Peptidrohstoffe und individuelle Peptidsynthese","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"NHD Technisches Team","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"Das technische Team von NHD verwaltet Katalogdokumentationen und Beweiszusammenfassungen f\u00fcr Forschungszwecke. Rezensierte Artikel verweisen auf von Experten begutachtete Artikel, Studienregister und beh\u00f6rdliche Aufzeichnungen, behalten Nullergebnisse und Studieneinschr\u00e4nkungen bei und unterscheiden ver\u00f6ffentlichte Interventionen von Katalogmaterialien. F\u00fcr die Strukturierung kann AI-unterst\u00fctztes Zeichnen verwendet werden; Quellenverkn\u00fcpfungen und Beweisgrenzen bleiben sichtbar. Bei dieser Arbeit handelt es sich nicht um eine unabh\u00e4ngige Begutachtung oder medizinische Beratung.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/de\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/comments?post=467"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/467\/revisions"}],"predecessor-version":[{"id":509,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/posts\/467\/revisions\/509"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/media\/632"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/media?parent=467"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/categories?post=467"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/de\/wp-json\/wp\/v2\/tags?post=467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}